Stockscreener 앱 받기
1.69
4.97%
0.08
시장 영업 전:
1.68
-0.01
-0.59%
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Stock Report: Should I average down on Dermata Therapeutics Inc Equity Warrant stockJuly 2025 Short Interest & Real-Time Buy Signal Notifications - baoquankhu1.vn
Surprises Report: What are Twin Hospitality Group Incs technical support levels - baoquankhu1.vn
Is Dermata Therapeutics Inc a momentum stockTrade Volume Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Opening: What are the future prospects of iSpecimen Inc2025 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Aug Weekly: Is Eureka Acquisition Corp Debt Equity Composite Units a cyclical or defensive stockGold Moves & Fast Moving Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Will Dermata Therapeutics Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Update & Entry Point Confirmation Signals - mfd.ru
Loss Report: Is Dermata Therapeutics Inc Equity Warrant stock risky to hold nowWeekly Gains Summary & Verified Entry Point Detection - baoquankhu1.vn
History Review: Can ALUR disrupt its industryJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
What is Dermata Therapeutics Inc.’s valuation compared to sectorJuly 2025 Spike Watch & Target Return Focused Picks - mfd.ru
Tuesday's after hours session: top gainers and losers - Chartmill
Meme Stocks: Is NRx Pharmaceuticals Inc Equity Warrant forming a breakout pattern2025 Market Overview & Expert Curated Trade Setups - baoquankhu1.vn
Dermata Therapeutics increases at-the-market offering by $705,000 - Investing.com Nigeria
Dermata Therapeutics increases at-the-market offering by $705,000 By Investing.com - Investing.com South Africa
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity - TipRanks
Market Movers | Winners: GRI, XXII, LRHC | Losers: NBY, EMAT, APUS - Trefis
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Gap Down: Why is AHLPRF stock going downMarket Activity Report & Accurate Intraday Trade Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Whats next for M3 Brigade Acquisition V Corp stockJuly 2025 Spike Watch & Precise Buy Zone Identification - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Aug Momentum: Does RRGB meet Warren Buffetts criteriaMarket Trend Summary & Precise Swing Trade Alerts - baoquankhu1.vn
Dermata receives Australian patent for Spongilla acne treatment By Investing.com - Investing.com Nigeria
Dermata receives Australian patent for Spongilla acne treatment - Investing.com
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - ACCESS Newswire
3.3M Australians with acne: Dermata's new treatment patent - Stock Titan
Will Dermata Therapeutics Inc. stock outperform growth indexesJuly 2025 Reactions & Stock Market Timing Techniques - bollywoodhelpline.com
Fundamentals Check: Will Dermata Therapeutics Inc benefit from seasonalityTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Can Grace Therapeutics Inc. weather a recessionRate Cut & Safe Capital Growth Trade Ideas - bollywoodhelpline.com
How buybacks impact Dermata Therapeutics Inc. stock value2025 Trade Ideas & Verified Stock Trade Ideas - ulpravda.ru
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthQuarterly Profit Report & AI Based Trade Execution Alerts - ulpravda.ru
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Will Dermata Therapeutics Inc. stock attract more institutional investorsFit and Size Notes & support options for steady strides - Улправда
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What dividend safety score for Dermata Therapeutics Inc. Equity Warrant stockJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Is Dermata Therapeutics Inc. stock a top pick in earnings seasonMarket Movers & Free Expert Verified Stock Movement Alerts - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTrade Exit Summary & Smart Investment Allocation Insights - Улправда
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Dermata Therapeutics Inc. stock trading at a premium valuationJuly 2025 Setups & Safe Entry Trade Signal Reports - Улправда
Aug Ideas: How Dermata Therapeutics Inc. Equity Warrant stock reacts to oil pricesGap Up & Scalable Portfolio Growth Methods - ulpravda.ru
Why Dermata Therapeutics Inc. Equity Warrant stock is a value investor pick2025 Market Trends & Community Consensus Trade Signals - Улправда
How Dermata Therapeutics Inc. stock benefits from global expansion2025 Biggest Moves & Technical Entry and Exit Tips - Улправда
Dermata Therapeutics Inc Equity Warrant Stock Analysis and ForecastBullish Engulfing Patterns & Free Phenomenal Capital Appreciation - earlytimes.in
Pre-market Movers: RSLS, STSS, VERO, KTTA... - RTTNews
Dermata Therapeutics announces $2.55M private offering - MSN
Top 5 stocks to watch today | December 30th - MSN
Dermata Therapeutics: Is Change on the Horizon? - StocksToTrade
Dermata Therapeutics: Unveiling Bold Moves - timothysykes.com
Top 5 Stocks To Watch Today | December 30th - MSN
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus - Benzinga
Dermata Therapeutics Raises Capital via December Private Placement - The Globe and Mail
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Dermata stock surges after closing $4.1 million private placement By Investing.com - Investing.com Australia
0.36%
1.16%
자본화:
|
볼륨(24시간):